MDT - Medtronic PLC - Stock Price & Dividends

Exchange: USA Stocks • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00BTN1Y115

Cardiac Devices, Surgical Instruments, Neurological Systems, Diabetes Management Systems

Medtronic plc is a global leader in developing, manufacturing, and selling innovative medical devices and therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company's Cardiovascular Portfolio segment is dedicated to improving heart health, offering a range of products such as implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices. Additionally, they provide cardiac ablation products, insertable cardiac monitor systems, and TYRX products, as well as remote monitoring and patient-centered software to help manage heart conditions.

Medtronic's Cardiovascular Portfolio also includes aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves. Furthermore, they offer percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products to support cardiovascular health.

The Medical Surgical Portfolio segment focuses on providing innovative solutions for surgeons, offering surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, and surgical artificial intelligence and robotic-assisted surgery products. They also provide hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. Moreover, they offer products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease.

The Neuroscience Portfolio segment is dedicated to providing products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, interventional radiologists, and ear, nose, and throat specialists. They offer image-guided surgery and intra-operative imaging systems, robotic guidance systems used in robot-assisted spine procedures, and therapies for vasculature in and around the brain.

The Diabetes Operating Unit segment is focused on improving the lives of people with diabetes, offering insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies.

Founded in 1949, Medtronic plc is headquartered in Dublin, Ireland, and is committed to improving healthcare outcomes and enhancing the quality of life for patients around the world. For more information, please visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for MDT - Medtronic PLC  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for MDT - Medtronic PLC  - Stock Price & Dividends

MDT Stock Overview

Market Cap in USD 104,133m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1978-01-13

MDT Stock Ratings

Growth 5y -15.3
Fundamental 45.1
Dividend 63.9
Rel. Performance vs Sector -1.20
Analysts 3.67/5
Fair Price Momentum 74.43 USD
Fair Price DCF 106.91 USD

MDT Dividends

Dividend Yield 12m 3.49%
Yield on Cost 5y 3.13%
Dividends CAGR 5y 5.34%
Payout Consistency 97.8%

MDT Growth Ratios

Growth 12m -7.57%
Growth Correlation 12m 12%
Growth Correlation 3m -27%
CAGR 5y -2.11%
CAGR/Mean DD 5y -0.10
Sharpe Ratio 12m -0.68
Alpha vs SP500 12m -29.30
Beta vs SP500 5y weekly 0.92
ValueRay RSI 69.16
Volatility GJR Garch 1y 20.43%
Price / SMA 50 -1.37%
Price / SMA 200 -0.31%
Current Volume 9292.5k
Average Volume 20d 6830.3k

External Links for MDT Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of MDT stocks?
As of July 20, 2024, the stock is trading at USD 79.48 with a total of 9,292,475 shares traded.
Over the past week, the price has changed by +1.96%, over one month by +0.02%, over three months by +0.89% and over the past year by -7.36%.
What are the forecast for MDT stock price target?
According to ValueRays Forecast Model, MDT Medtronic PLC will be worth about 81.7 in July 2025. The stock is currently trading at 79.48. This means that the stock has a potential upside of +2.73%.
Issuer Forecast Upside
Wallstreet Target Price 92.4 16.3
Analysts Target Price 90.4 13.8
ValueRay Target Price 81.7 2.73

Medtronic PLC: Pioneering Medical Technologies

History of Innovation

Medtronic PLC began its journey in 1949, transforming the medical device industry. Founded by Earl Bakken and Palmer Hermundslie in Minneapolis, the company initially repaired medical equipment. The invention of the first battery-powered pacemaker in 1957 marked Medtronic's expansion into medical device manufacturing, setting the stage for decades of innovation in patient care.

Core Business: Life-Saving Devices

At the heart of Medtronic's operations is the development and manufacturing of groundbreaking medical devices. The company focuses on several key areas, including cardiology, diabetes, and minimally invasive therapies. These devices, such as pacemakers, insulin pumps, and surgical tools, are central to its mission of alleviating pain, restoring health, and extending life for millions worldwide.

Expanding Horizons: Side Businesses

Beyond its primary focus, Medtronic has diversified into related healthcare services and solutions. This includes monitoring and diagnostic services, healthcare management software, and other technologies designed to improve patient outcomes and streamline healthcare processes. These side businesses complement its core product offerings, addressing a broader range of healthcare needs.

Current Market Status

As of 2023, Medtronic PLC remains a leading force in the global medical technology market. With operations in over 150 countries, it continues to innovate, driven by a commitment to improving patient lives. Despite challenges in the global market, Medtronic's diverse product portfolio and strategic expansions position it well for future growth. The resilience and importance of the healthcare sector underscore Medtronic's ongoing development and relevance in a world increasingly reliant on medical technology solutions.